Dive into 2025's cutting-edge medical education technologies like immersive training, interactive data visualization, and ...

Regeneron Pharmaceuticals has announced that it will be gaining rights to Hansoh Pharmaceuticals’ investigational dual ...

The drug has been approved in combination with the chemotherapy regimen etoposide, cyclophosphamide, doxorubicin, dacarbazine ...

Dermaliq Therapeutics and global non-profit organisation DEBRA Research have entered into a partnership aimed at advancing ...

Inizio Evoke has announced the appointment of Matthew Hoelzle as chief medical officer. Hoelzle brings extensive industry ...

Many companies are working globally to widen access to clinical trials through initiatives in research and development, ...

At HCG, our goal is medical education that helps HCPs meet their patients where they are. Our commercial and marketing ...

ISPOR’s annual meeting in Montreal this May was packed with opportunities to explore the latest trends, insights, and ...

The Medscape Education Global team will be travelling to Amsterdam for the HLTH Europe 2025 conference to showcase the power ...

The phase 3 IMforte study randomised adults with extensive-stage SCLC to receive Roche’s PD-L1 inhibitor Tecentriq ...

BioNTech’s BNT327 is being evaluated in multiple clinical trials, including phase 3 studies in first-line lung cancer ...

AstraZeneca (AZ) has announced that a wider range of chronic kidney disease (CKD) patients across England and Wales will be ...